Handa Pharmaceuticals, Inc.

TPEX:6620 Stock Report

Market Cap: NT$17.6b

Handa Pharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Toshiyo Chen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure7.8yrs
Board average tenureno data

Recent management updates

Recent updates

Handa Pharmaceuticals'(GTSM:6620) Share Price Is Down 26% Over The Past Three Years.

Feb 24
Handa Pharmaceuticals'(GTSM:6620) Share Price Is Down 26% Over The Past Three Years.

We Think Handa Pharmaceuticals (GTSM:6620) Can Afford To Drive Business Growth

Dec 29
We Think Handa Pharmaceuticals (GTSM:6620) Can Afford To Drive Business Growth

CEO

Toshiyo Chen

no data

Tenure

Mr. Toshiyo Chen serves as General Manager and Director of Handa Pharmaceuticals, Inc. Mr. Chen has corporate management experience, specializes in the management, corporate governance, negotiation, market...

Leadership Team

NamePositionTenureCompensationOwnership
Fang-Yu Liu
Founder & Chairmanno datano datano data
Toshiyo Chen
GM & Directorno datano datano data
Chi-Yu Yang
Vice President of Financeno datano datano data
Guo-Chun Song
Chief Technology Officerno datano datano data
Zhong-Yi Duan
Vice President of Regulation7.7yrsno datano data
Mei-Fang Chang
Senior VP of Quality Affairs & Director7.8yrsno datano data
Stephen Cary
Senior Vice President of Business Development7.8yrsno datano data

7.8yrs

Average Tenure

Experienced Management: 6620's management team is seasoned and experienced (7.8 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.